课题基金 / 基金详情

CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES

CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
批准号:
10245991
负责人:
STEPHANIE TEAL
金额:
$1.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-08-01 至 2021-07-31

项目摘要

项目成果

STEPHANIE TEAL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
There is a demand for new methods of contraception that can provide effective protection against unintended pregnancy as well as reduce the risk of venous thromboembolism (VTE), particularly for obese women. The mission of the Contraceptive Clinical Trials Network (CCTN) is to develop protocols and conduct clinical trials that will assist in product development with the end goal to provide effective and safe contraception for women. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has a mission to develop safe and effective contraceptives for women, including obese women and women who have medical conditions for which current contraceptive products are contraindicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
  • 批准号:
    10891325
  • 项目类别:
  • 资助金额:
    $0.17万
  • 财政年份:
    2023
  • 负责人:
    STEPHANIE TEAL
  • 依托单位:
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION
  • 批准号:
    9795853
  • 项目类别:
  • 资助金额:
    $21.4万
  • 财政年份:
    2018
  • 负责人:
    STEPHANIE TEAL
  • 依托单位:
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION
  • 批准号:
    10936500
  • 项目类别:
  • 资助金额:
    $6.59万
  • 财政年份:
    2018
  • 负责人:
    STEPHANIE TEAL
  • 依托单位:
CCTN-PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONOGESTREL BUTANOATE FOR FEMALE CONTRACEPTION
  • 批准号:
    10497859
  • 项目类别:
  • 资助金额:
    $11.52万
  • 财政年份:
    2018
  • 负责人:
    STEPHANIE TEAL
  • 依托单位:
海外基金